Estimating proportion of days covered (PDC) using real-world online medicine suppliers’ datasets
Authors:
Top Cited Papers
Open Access
- 29 December 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 14 (1) , 1-14
Abstract
Background: The proportion of days covered (PDC) is used to estimate medication adherence by looking at the proportion of days in which a person has access to the medication, over a given period of interest. This study aimed to adapt the PDC algorithm to allow for plausible assumptions about prescription refill behaviour when applied to data from online pharmacy suppliers. Methods: Three PDC algorithms, the conventional approach (PDC1) and two alternative approaches (PDC2 and PDC3), were used to estimate adherence in a real-world dataset from an online pharmacy. Each algorithm has different denominators and increasing levels of complexity. PDC1, the conventional approach, is the total number of days between first dispensation and a defined end date. PDC2 counts the days until the end of supply date. PDC3 removes from the denominator specifically defined large gaps between refills, which could indicate legitimate reasons for treatment discontinuation. The distribution of the three PDCs across four different follow-up lengths was compared. Results: The dataset included people taking ACE inhibitors (n = 65,905), statins (n = 100,362), and/or thyroid hormones (n = 30,637). The proportion of people taking ACE inhibitors with PDC ≥ 0.8 was 50–74% for PDC1, 81–91% for PDC2, and 86–100% for PDC3 with values depending on drug and length of follow-up. Similar ranges were identified in people taking statins and thyroid hormones. Conclusion: These algorithms enable researchers and healthcare providers to assess pharmacy services and individual levels of adherence in real-world databases, particularly in settings where people may switch between different suppliers of medicines, meaning an individual supplier’s data may show temporary but legitimate gaps in access to medication. Accurately identifying problems with adherence provides the foundation for opportunities to improve experience, adherence and outcomes and to reduce medicines wastage. Research with people taking medications and prescribers is required to validate the algorithms’ assumptions.Keywords
Funding Information
- Pharmacy2U
This publication has 16 references indexed in Scilit:
- Medication Adherence Measures: An OverviewBioMed Research International, 2015
- Healthcare provider targeted interventions to improve medication adherence: systematic review and meta-analysisInternational Journal Of Clinical Practice, 2015
- Improving health outcomes by reducing medicines wastePrescriber, 2014
- Understanding Patients’ Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns FrameworkPLOS ONE, 2013
- Assessing medication adherence: options to considerInternational Journal of Clinical Pharmacy, 2013
- A new taxonomy for describing and defining adherence to medicationsBritish Journal of Clinical Pharmacology, 2012
- A Checklist for Medication Compliance and Persistence Studies Using Retrospective DatabasesValue in Health, 2007
- Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred MeasuresAnnals of Pharmacotherapy, 2006
- Patient-centred advice is effective in improving adherence to medicinesInternational Journal of Clinical Pharmacy, 2006
- Effectiveness of Interventions by Community Pharmacists to Improve Patient Adherence to Chronic Medication: A Systematic ReviewAnnals of Pharmacotherapy, 2005